XCL1 and cancer: The pivotal role of XCL1 in activation of osteoclasts and osteoblasts highlights it as a therapeutic target for aseptic loosening and other diseases associated with bone destruction such as rheumatoid arthritis, Paget's disease, cancer bone metastases, and osteoporosis.